Alnylam Pharmaceuticals (ALNY) Treasury Shares (2011 - 2025)

Alnylam Pharmaceuticals has reported Treasury Shares for 14 years, with the latest figure at $1.7 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 0.64% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (up 0.64% YoY), and the FY2025 full-year result was $1.7 million, up 0.64% from the prior year.
• Treasury Shares for Q4 2025 stood at $1.7 million, up from $1.7 million in the prior quarter.
• The five-year high for Treasury Shares was $1.7 million in Q4 2025, with the low at $75000.0 in Q4 2021.
• Historically, Treasury Shares has averaged $972200.0 across 5 years, with a median of $1.0 million in 2023.
• Annual changes were most pronounced in 2021 — Treasury Shares sank 92.81% — and 2022, when it jumped 289.33%.
• Alnylam Pharmaceuticals' Treasury Shares stood at $75000.0 in 2021, then jumped by 289.33% to $292000.0 in 2022, then jumped by 253.77% to $1.0 million in 2023, then jumped by 66.99% to $1.7 million in 2024, then advanced by 0.64% to $1.7 million in 2025.
• The last three Treasury Shares figures came in at $1.7 million (Q4 2025), $1.7 million (Q4 2024), and $1.0 million (Q4 2023), per Business Quant data.